Literature DB >> 6345452

Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog.

R J Workman, M I Shaff, R V Jackson, J Diggs, M G Frazer, C Briscoe.   

Abstract

Deterioration in renal function has been observed after the use of intravascular contrast media. In an attempt to identify factors responsible for this phenomenon, meglumine iothalamate (Conray 60), in a dosage range of 2.5-3.3 ml/kg, was injected as a bolus into the aorta of dogs. Serial measurements were made of parameters of renal function as well as of changes in aortic and renal venous levels of angiotensin II, renin activity, and 6-keto-PGF1 alpha, the stable metabolite of prostacyclin. The major findings were (1) an initial, brief increase followed by approximately a 20% sustained decrease in renal blood flow and creatinine clearance, (2) no significant changes in angiotensin II and renin levels, and (3) a significant decline in the renal secretory rate of 6-keto-PGF1 alpha. These observations suggest that the suppression of prostacyclin, rather than the activation of the renin-angiotensin system, may contribute to the renal function changes attending the use of intravascular contrast media.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345452     DOI: 10.1097/00004424-198303000-00012

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

1.  Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

Authors:  K Spargias; E Adreanides; G Giamouzis; S Karagiannis; A Gouziouta; A Manginas; V Voudris; G Pavlides; D V Cokkinos
Journal:  Eur J Clin Pharmacol       Date:  2006-07-11       Impact factor: 2.953

2.  The role of endothelin in radiocontrast nephropathy.

Authors:  A Anarat; N Duman; A Noyan; M Kibar; R Anarat
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

3.  Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.

Authors:  Thomas M Kitzler; Aala Jaberi; Gerald Sendlhofer; Peter Rehak; Christian Binder; Eva Petnehazy; Rudolf Stacher; Peter Kotanko
Journal:  Wien Klin Wochenschr       Date:  2012-04-24       Impact factor: 1.704

4.  Radiocontrast-induced renal failure.

Authors:  R T Misson; R E Cutler
Journal:  West J Med       Date:  1985-05

Review 5.  Contrast-induced nephropathy: pathogenesis and prevention.

Authors:  Robert E Cronin
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

6.  Incidence of contrast-induced nephropathy in hospitalised patients with cancer.

Authors:  Irfan Cicin; Bulent Erdogan; Emrah Gulsen; Sernaz Uzunoglu; Necdet Sut; Esma Turkmen; Hilmi Kodaz; Sedat Ustundag
Journal:  Eur Radiol       Date:  2013-09-25       Impact factor: 5.315

Review 7.  Pharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Pattharawin Pattharanitima; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

Review 8.  Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?

Authors:  Jolanta Małyszko; Leszek Kozlowski; Klaudia Kozłowska; Maciej Małyszko; Jacek Małyszko
Journal:  Oncotarget       Date:  2017-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.